These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 25316321)

  • 1. Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations.
    LLerena A; Naranjo ME; Rodrigues-Soares F; Penas-LLedó EM; Fariñas H; Tarazona-Santos E
    Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1569-83. PubMed ID: 25316321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes.
    Céspedes-Garro C; Fricke-Galindo I; Naranjo ME; Rodrigues-Soares F; Fariñas H; de Andrés F; López-López M; Peñas-Lledó EM; LLerena A
    Expert Opin Drug Metab Toxicol; 2015; 11(12):1893-905. PubMed ID: 26595139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations.
    Fricke-Galindo I; Céspedes-Garro C; Rodrigues-Soares F; Naranjo ME; Delgado Á; de Andrés F; López-López M; Peñas-Lledó E; LLerena A
    Pharmacogenomics J; 2016 Apr; 16(2):113-23. PubMed ID: 26503820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of CYP2D6 ultrarapid metabolizer genotypes in an Ashkenazi Jewish population from Argentina.
    Moya G; Dorado P; Ferreiro V; Naranjo MEG; Peñas-Lledó EM; LLerena A
    Pharmacogenomics J; 2017 Jul; 17(4):378-381. PubMed ID: 27068265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2D6 gene polymorphisms and predicted phenotypes in eight indigenous groups from northwestern Mexico.
    Lazalde-Ramos BP; Martínez-Fierro Mde L; Galaviz-Hernández C; Garza-Veloz I; Naranjo ME; Sosa-Macías M; Llerena A
    Pharmacogenomics; 2014 Feb; 15(3):339-48. PubMed ID: 24533713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.
    Dorado P; Cáceres MC; Pozo-Guisado E; Wong ML; Licinio J; Llerena A
    Biotechniques; 2005 Oct; 39(4):571-4. PubMed ID: 16235570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphism in cytochrome P450 2D6 (CYP2D6): Population distribution of CYP2D6 activity.
    Neafsey P; Ginsberg G; Hattis D; Sonawane B
    J Toxicol Environ Health B Crit Rev; 2009; 12(5-6):334-61. PubMed ID: 20183526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results and challenges of Cytochrome P450 2D6 (CYP2D6) testing in an ethnically diverse South Florida population.
    Salyakina D; Roy S; Wang W; Oliva M; Akhouri R; Sotto I; Mulas N; Solano R; Fernández JR; Sanchez S; Shamshad U; Perlyn C; McCafferty-Fernandez J
    Mol Genet Genomic Med; 2019 Sep; 7(9):e922. PubMed ID: 31389673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.
    Dorado P; Cáceres M; Pozo-Guisado E; Wong ML; Licinio J; Llerena A
    Biotechniques; 2005 Oct; 39(10 Suppl):S571-4. PubMed ID: 18957039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.
    Naranjo MG; Rodrigues-Soares F; Peñas-Lledó EM; Tarazona-Santos E; Fariñas H; Rodeiro I; Terán E; Grazina M; Moya GE; López-López M; Sarmiento AP; Calzadilla LR; Ramírez-Roa R; Ortiz-López R; Estévez-Carrizo FE; Sosa-Macías M; Barrantes R; LLerena A;
    OMICS; 2018 Sep; 22(9):575-588. PubMed ID: 30183544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population.
    Griese EU; Asante-Poku S; Ofori-Adjei D; Mikus G; Eichelbaum M
    Pharmacogenetics; 1999 Dec; 9(6):715-23. PubMed ID: 10634134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of the CYP2D6*10 (C100T), *4 (G1846A), and *14 (G1758A) alleles among Iranians of different ethnicities.
    Bagheri A; Kamalidehghan B; Haghshenas M; Azadfar P; Akbari L; Sangtarash MH; Vejdandoust F; Ahmadipour F; Meng GY; Houshmand M
    Drug Des Devel Ther; 2015; 9():2627-34. PubMed ID: 25999696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism?
    Løvlie R; Daly AK; Matre GE; Molven A; Steen VM
    Pharmacogenetics; 2001 Feb; 11(1):45-55. PubMed ID: 11207030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of single nucleotide polymorphisms of CYP2D6 in the Czech population.
    Buzková H; Pechandová K; Slanar O; Perlík F
    Cell Biochem Funct; 2008; 26(1):76-81. PubMed ID: 17311358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.
    Zhou SF
    Clin Pharmacokinet; 2009; 48(11):689-723. PubMed ID: 19817501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation, sequence and genotyping of the drug metabolizer CYP2D6 gene in the Colombian population.
    Isaza CA; Henao J; López AM; Cacabelos R
    Methods Find Exp Clin Pharmacol; 2000 Nov; 22(9):695-705. PubMed ID: 11294012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency of CYP2D6 ultrarapid metabolizers in Spain: controversy about their misclassification in worldwide population studies.
    Naranjo ME; de Andrés F; Delgado A; Cobaleda J; Peñas-Lledó EM; LLerena A
    Pharmacogenomics J; 2016 Oct; 16(5):485-90. PubMed ID: 27272044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No association between CYP2D6 polymorphism and Alzheimer's disease in an Italian population.
    Scordo MG; Dahl ML; Spina E; Cordici F; Arena MG
    Pharmacol Res; 2006 Feb; 53(2):162-5. PubMed ID: 16337409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population.
    Griese EU; Zanger UM; Brudermanns U; Gaedigk A; Mikus G; Mörike K; Stüven T; Eichelbaum M
    Pharmacogenetics; 1998 Feb; 8(1):15-26. PubMed ID: 9511177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complexities of CYP2D6 gene analysis and interpretation.
    Gaedigk A
    Int Rev Psychiatry; 2013 Oct; 25(5):534-53. PubMed ID: 24151800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.